Skip to main content
. 2013 Sep;23(7):468–480. doi: 10.1089/cap.2012.0023

Table 2.

Extent of Double-Blind Exposure (Safety Population)

  Placebo (n=157) Escitalopram (n=155)
Treatment duration, days, mean±SDa 100.23±66.70 96.62±64.13
Overall mean dosage in mg/day, mean±SD 14.04±3.5
Overall mean dosage in tablets/day, mean±SD 1.44±0.32 1.40±0.35
Patient-yearsb 43.08 41.00
a

Treatment duration=last date of double-blind study drug before taper- down–first date of double-blind study drug+1.

b

Patient-years=total treatment duration in days/365.25.